Intestipret

Peppermint Oil, the active ingredient in Intestipret, is a botanical oil presented as an oral preparation for oral use. It may help relieve occasional abdominal discomfort and bloating associated with functional gastrointestinal conditions. GNH USA supplies Intestipret as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Intestipret is used as a botanical antispasmodic for functional gastrointestinal disorders. - Irritable Bowel Syndrome: may help reduce abdominal pain and bloating. - Functional Dyspepsia: may alleviate upper abdominal discomfort and fullness. - Minor Gastrointestinal Spasms: may ease cramping and irregular bowel movements.

Common Side Effects: - Heartburn: mild acid reflux may occur. - Nausea: occasional feeling of queasiness. - Mouth irritation: tingling or burning sensation. - Allergic skin reaction: mild rash or itching. - Headache: transient headache reported. - Dizziness: light‑headed feeling in some users.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring emergency care. - Severe abdominal pain: intense, persistent pain. - Facial swelling: swelling of lips, tongue, or face. - Breathing difficulty: shortness of breath or wheezing. - Hypotension: sudden drop in blood pressure. - Hepatic injury: rare liver enzyme elevation.

Intestipret should be used with caution in the following situations: - Children: not recommended unless advised by a healthcare professional. - Hypersensitivity: avoid if known allergy to peppermint or related plants. - Gastroesophageal reflux disease (GERD): may exacerbate symptoms. - Pregnancy: safety not established; consult a physician before use. - Breastfeeding: insufficient data; discuss with a healthcare provider. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Intestipret may interact with other medicines as follows: Major Interactions (Avoid): - Anticholinergic drugs: combined use may cause excessive gastrointestinal motility. - CYP2A6 inhibitors: peppermint oil can inhibit metabolism, increasing levels of CYP2A6 substrates. Moderate Interactions (Monitor Closely): - Antacids: may reduce the antispasmodic effect of peppermint oil. - Warfarin: potential to alter bleeding risk; monitor INR. - Other herbal preparations: additive antispasmodic activity may increase side‑effect risk.